Vanguard Investments Australia, Ltd.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1550100
Victoria, C3
Position in ALNY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$21,774,554
New position
Shares Held
65,810
first reported quarter
Ownership
0.050%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vanguard Investments Australia, Ltd. holds $248,175,676 across 148 Biotechnology names. ALNY ranks #3 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
126,261 | $56,380,586 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
51,305 | $39,640,295 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
65,810 | $21,774,554 | |
| 4 | INSM |
INSMED Inc
|
105,805 | $17,301,233 | |
| 5 | RPRX |
Royalty Pharma plc
|
202,080 | $9,693,777 | |
| 6 | INCY |
Incyte Corp
|
82,818 | $7,794,830 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
67,421 | $6,556,692 | |
| 8 | MRNA |
Moderna, Inc.
|
89,128 | $4,527,702 |
All Filings in ALNY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,774,554 | 65,810 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||